News >

Multiagent Regimens Progress Further in Frontline Myeloma

Caroline Seymour
Published: Monday, Jul 29, 2019

Kenneth C. Anderson, MD

Kenneth C. Anderson, MD

The pace of progress in multiple myeloma is such that patients are living progression-free for more than 8 years, said Kenneth C. Anderson, MD. This progress is, in large part, due to the increasing number of triplet therapies that have become available to patients, irrespective of transplant eligibility.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication